Top-News

Redhill Biopharma Aktie (ADR) News

Aktie
WKN:  A40MF2 ISIN:  US7574683014 US-Symbol:  RDHL Branche:  Biotechnologie Land:  Israel
1,185 $
-0,015 $
-1,25%
1,0177 € 05.12.25
Depot/Watchlist
Marktkapitalisierung *
30,66 Tsd. €
Streubesitz
-
KGV
-
Faktor
0.001
Originalaktie
IL0011223810

Redhill Biopharma Aktie (ADR) News

27.02.25 - PR Newswire
RedHill Presents Business Update at the Sachs' European Life Sciences CEO Forum
RedHill Presents Business Update at the Sachs' European Life Sciences CEO Forum PR Newswire
25.02.25 - PR Newswire
RedHill Licenses RHB-102 for Commercialization Worldwide Excluding North America to Hyloris for up to $60 Million in Potential Milestone Payments Plus Royalties
RedHill Licenses RHB-102 for Commercialization Worldwide Excluding North America to Hyloris for up to $60 Million in Potential Milestone Payments Plus Royalties PR Newswire
04.02.25 - PR Newswire
RedHill Announces Initiation of Phase 2 Study of Opaganib and Darolutamide in Advanced Prostate Cancer
RedHill Announces Initiation of Phase 2 Study of Opaganib and Darolutamide in Advanced Prostate Cancer PR Newswire
21.01.25 - PR Newswire
RedHill's Talicia® Adds 8 Million Lives With Coverage by Humana®'s Part D Plan. Also, New Data Supporting Simplified Three-Times Daily Talicia Dosing Published
RedHill's Talicia® Adds 8 Million Lives With Coverage by Humana®'s Part D Plan. Also, New Data Supporting Simplified Three-​Times Daily Talicia Dosing Published PR Newswire
10.12.24 - PR Newswire
Radioprotective Activity of RedHill's Opaganib for GI-ARS Confirmed in New RNCP/NIAID Study - Discussions Ongoing with U.S. Government on Advanced Development
Radioprotective Activity of RedHill's Opaganib for GI-ARS Confirmed in New RNCP/NIAID Study - Discussions Ongoing with U.S. Government on Advanced Development PR Newswire

Newssuche

Videos

newspaper
06.12.25
Master the Trading!
In diesem Trading-​Webinar haben wir von A bis Z den Aufbau professionellen Tradings thematisiert und ... Mehr »